Skip to main content

Table 1 Main statistical parameters of the trial calculation

From: The PACOVAR-trial: A phase I/II study of pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant recurrent, pre-treated ovarian cancer

Parameter

 

p0

10%

p1

30%

α

5%

β

10%

Number of patients

 

Stage I

18

Stage II

17

Rejection of therapy

 

Stage I

0 - 2 responder among 18 patients

Stage II

0 - 6 responder among 35 patients